| |||||||||
|
Supplement to: Nissen SE. ADHD Drugs and Cardiovascular Risk. N Engl J Med 2006;354(14):1445-8.
Steven Nissen is the interim chair of the Department of Cardiovascular Medicine at the Cleveland Clinic, Cleveland, and was a consultant to the FDA’s Drug Safety and Risk Management Advisory Committee for the hearings on ADHD drugs. Rachel Gotbaum, the interviewer, is an independent producer based in Boston. |
|
|
| |||||||||
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |